Search

This course focuses on the science of U=U and how to effectively spread the message in a clear, stigma-free manner.

Bictegravir + lenacapavir – an emerging duo

CATIE strengthens Canada’s response to HIV, hepatitis C and the toxic drug crisis by bridging research and practice. We connect healthcare and community-based service providers with the latest…

Placeholder

Placeholder

Placeholder

This information session presents the safety and efficacy of long-acting PrEP, an HIV prevention method recently approved by Health Canada. Administered by a healthcare professional, this new…

Placeholder

This report highlights key themes and recommendations for policy, practice and programs that emerged from a bilingual meeting on hepatitis C elimination in Canada.

Exploring weight changes with different integrase inhibitors

This webinar provides an overview of mpox epidemiology and community-based responses, including key lessons, challenges and successes. Participants gain a deeper understanding of mpox transmission…

Post-exposure prophlyaxis (PEP) can prevent HIV after an exposure, if taken as soon as possible. To minimize delays in starting, “PEP in Pocket” offers this medication to patients in advance. Toronto…